Short-term erythrosine B-induced inhibition of the brain regional serotonergic activity suppresses motor activity (exploratory behavior) of young adult mammals

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 4, 2009, Pages 574-582

  Dalal, Arindam ^a   Poddar, Mrinal K ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Brain regions; Erythrosine; Motor activity; Serotonergic activity

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CLORGYLINE; ERYTHROSINE; PARGYLINE; SELEGILINE; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; DETERIORATION; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG INHIBITION; DRUG MEGADOSE; HIPPOCAMPUS; HYPOTHALAMUS; JUVENILE ANIMAL; LOW DRUG DOSE; MALE; MAMMAL; MEDULLA OBLONGATA; MOTOR ACTIVITY; NEUROMODULATION; NONHUMAN; PONS; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SINGLE DRUG DOSE; STEADY STATE;

ANIMALS; BRAIN; CLORGYLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROSINE; EXPLORATORY BEHAVIOR; FOOD COLORING AGENTS; HYDROXYINDOLEACETIC ACID; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; RATS; RECEPTORS, SEROTONIN; SELEGILINE; SEROTONIN; TIME FACTORS; TISSUE DISTRIBUTION;

MAMMALIA; RATTUS;

EID: 67349110411     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.02.010     Document Type: Article

References (72)

1. Abdel Aziz A.H., Shouman S.A., Attia A.S., and Saad S.F. A study on the reproductive toxicity of erythrosine in male mice. Pharmacol Res 35 (1997) 457-462
2. Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113 (2007) 296-320
3. Augustine G.J., and Levitan H. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye erythrosine B. J Physiol 334 (1983) 47-63
4. Bankson M.G., and Cunningham K.A. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297 (2001) 846-852
5. Barroso N., and Rodriguez M. Action of beta phenyl ethylamine and related amines on nigrostriatal dopamine neurotransmission. Eur J Pharmacol 297 (1996) 195-203
6. Bateman B., Warner J.O., Hutchinson E., Dean T., Rowlandson P., Gant C., et al. The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child 89 (2004) 506-511
7. Bennett Jr. J.P., and Snyder S.H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol 12 (1976) 373-389
8. Boris M., and Mandel F.S. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy 72 (1994) 462-468
9. Branchereau P., Chapron J., and Meyrand P. Descending 5-hydroxytryptamine raphe inputs repress the expression of serotonergic neurons and slow the maturation of inhibitory systems in mouse embryonic spinal cord. J Neurosci 22 (2002) 2598-2606
10. Brennan A.R., and Arnsten A.F. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann N Y Acad Sci 1129 (2008) 236-245
11. Budavari S. The Merck Index: an encyclopedia of chemicals, drugs and biologicals. 11th ed. (1989), Merck & Co., Rahway, NJ, U.S.A. centennial ed.
12. Butcher S.P., Fairbrother I.S., Kelly J.S., and Arbuthnott G.W. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. J Neurochem 55 (1990) 981-988
13. Cazalets J.R., Gardette M., and Hilaire G. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. J Neurophysiol 83 (2000) 2468-2470
14. Celada P., and Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedeberg's Arch Pharmacol 347 (1993) 583-590
15. Colombini M., and Wu C.Y. A food dye, erythrosine B, increases membrane permeability to calcium and other ions. Biochim Biophys Acta 648 (1981) 49-54
16. Feingold B.F. Hyperkinesis and learning disabilities linked to artificial food flavors and colours. Am J Nurs 75 (1975) 797-803
17. Fitzgerald L.W., Kaplinsky L., and Kimmelberg H.K. Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J Neurochem 55 (1990) 2008-2014
18. Food additives in Europe 2000 Status of safety assessments of food additives presently permitted in the EU. Prepared and published by the Nordic Council of Ministers, Tema Nord; 2002. p. 92-101.
19. Fowler C.J., and Tipton K.F. Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem 38 (1982) 733-736
20. Gardner D.F., Utiger R.D., Schwartz S.L., Witorsch P., Meyers B., Braverman L.E., et al. Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on thyroid function in normal men. Toxicol. Appl Pharmacol 91 (1987) 299-304
21. Giros B., Jaber M., Jones S., Wightman R.M., and Caron M. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
22. Grailhe R., Waeber C., Dulawa S.C., Hornung J.P., Zhuang X., Brunner D., et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron 22 (1999) 581-591
23. Gray E.G., and Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96 (1962) 79-88
24. Green A.L., and Haughton T.M. A colorimetric method for the estimation of monoamine oxidase. Biochem J 78 (1961) 172-175
25. Green A.R., and Youdim M.B. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol 55 (1975) 415-422
26. Guha S.R. Inhibition of purified rat liver mitochondrial monoamine oxidase by trans-2-phenyl-cyclopropylamine. Biochem Pharmacol 15 (1966) 161-168
27. Hechtman L. Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review. J Psychiatry Neurosci 19 (1994) 193-201
28. Heffron J.J., O'Callaghan A.M., and Duggan P.F. Food dye, erythrosin B, inhibits ATP-dependent calcium ion transport by brain microsomes. Biochem Int 9 (1984) 557-562
29. Hirohashi T., Terasaki T., Shigetoshi M., and Sugiyama Y. In vivo and in vitro evidence for nonrestricted transport of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier. J Pharmacol Exp Ther 280 (1997) 813-819
30. Hnatowich M., and Labella F.S. Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea-pig heart by the food dye erythrosine. Mol Pharmacol 22 (1982) 687-692
31. Howell L.L., and Kimmel H.L. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75 (2008) 196-217
32. Jacobs B.L., Martín-Cora F.J., and Fornal C.A. Activity of medullary serotonergic neurons in freely moving animals. Brain Res Rev 40 (2002) 45-52
33. Jahng J.W., Houpt T.A., Wessel T.C., Chen K., Shih J.C., and Joh T.H. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 25 (1997) 30-36
34. Jamaluddin S., and Poddar M.K. Brain regional gamma-aminobutyric acid (GABA) and locomotor activity: effect of long-term aldrin exposure. Pol J Pharmacol 55 (2003) 371-382
35. JECFA, WHO Food Additives Series 28: Toxicology Evaluation of Certain Food Additives and Contaminants. Joint FAO/WHO Expert Committee on Food Additives. International Programme on Chemical Safety (IPCS) Geneva, 1991, pp. 171-81.
36. Keenan A., and Johnson F.N. Development of behavioural tolerance to nicotine in rat. Experientia 28 (1972) 428-429
37. Kelley A.E. Locomotor activity and exploration. In: Sahgal A. (Ed). Behavioral neuroscience. A practical approach vol. 2 (1993), IRL Press, New York 1-4
38. Lafferman J.A., and Silbergeld E.K. Erythrosin B inhibits dopamine transport in rat caudate synaptosomes. Science 205 (1979) 410-412
39. Larsen J.C. Risk assessment of chemicals in European traditional foods. Trends Food Sci Technol 17 (2006) 471-481
40. Levitan H. Food, drug, and cosmetic dyes: biological effects related to lipid solubility. Proc Natl Acad Sci U S A 74 (1977) 2914-2918
41. Levitan H., Ziylan Z., Smith Q.R., Takasato Y., and Rapoport S.I. Brain uptake of a food dye, erythrosin B, prevented by plasma protein binding. Brain Res 322 (1984) 131-134
42. Levitt P., Pintar J.E., and Breakefield X.O. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci U S A 79 (1982) 6385-6389
43. Liu J., and Jordan L.M. Stimulation of the parapyramidal region of the neonatal rat brain stem produces locomotor-like activity involving spinal 5-HT7 and 5-HT2A receptors. J Neurophysiol 94 (2005) 1392-1404
44. Logan W.J., and Swanson J.M. Erythrosin B inhibition of neurotransmitter accumulation by rat brain homogenate. Science 206 (1979) 363-364
45. Lowry O.H., Rosebrough N.J., Farr A.L., and Randal R.J. Protein measurement with Folin-phenol reagent. J Biol Chem 193 (1951) 265-275
46. McCann D., Barrett A., Cooper A., Crumpler D., Dalen L., Grimshaw K., et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370 (2007) 1560-1567
47. Nakamura M., Ishii A., and Nakahara D. Characterization of p-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis study. Eur J Pharmacol 349 (1998) 163-169
48. Okuda C., Segal D.S., and Kuczenski R. Deprenyl alters behaviour and caudate dopamine through an amphetamine-like action. Pharmacol Biochem Behav 43 (1992) 1075-1080
49. Peroutka S.J., and Snyder S.H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16 (1979) 687-699
50. Pflieger J.F., Clarac F., and Vinay L. Postural modifications and neuronal excitability changes induced by a short-term serotonin depletion during neonatal development in the rat. J Neurosci 22 (2002) 5108-5117
51. Poddar M.K., and Dewey W.L. Effect of cannabinoids on catecholamine uptake and release in hypothalamus and striatal synaptosomes. J Pharmacol Exp Ther 214 (1980) 63-67
52. Rao P., Bhat R.V., Sudershan R.V., and Prasanna K.T. Consumption of synthetic food colours during festivals in Hyderabad, India. Br Food J 107 (2005) 276-284
53. Sasaki Y.F., Kawaguchi S., Kamaya A., Ohshita M., Kabasawa K., Iwama K., et al. The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat Res 519 (2002) 103-119
54. Scapagnini U., Vandenbroeck R., and De Schaepdryver A. Simultaneous estimation of 5-hydroxytryptamine and 5-hydroxyindol-3-acetic acid in rat brain. Biochem Pharmacol 18 (1969) 938-940
55. Schab D.W., and Trinh N.H. Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. J Dev Behav Pediatr 25 (2004) 423-434
56. Schmidt B.J., and Jordan L.M. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res Bull 53 (2000) 689-710
57. Silbergeld E.K. Erythrosin B is a specific inhibitor of high affinity 3H-ouabain binding and ion transport in rat brain. Neuropharmacology 20 (1981) 87-90
58. Sleight A.J., Marsden C.A., Martin K.F., and Palfreyman M.G. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and l-tryptophan. Br J Pharmacol 93 (1988) 303-310
59. Stein D.J., Fan J., Fossella J., and Russell V.A. Inattention and hyperactivity-impulsivity: psychobiological and evolutionary underpinnings of ADHD. CNS Spectr 12 190 (2007) 193-196
60. +)-ATPase: biphasic interaction with erythrosin B. Biochem. Pharmacol 31 (1982) 2185-2190
61. Tanaka T. Reproductive and neurobehavioural toxicity study of erythrosine administered to mice in the diet. Food Chem Toxicol 39 (2001) 447-454
62. Tanaka T. Reproductive and neurobehavioural toxicity study of tartrazine administered to mice in the diet. Food Chem Toxicol 44 (2006) 179-187
63. Tekes K., and Magyar K. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions. Neurobiology (Bp) 8 (2000) 257-264
64. Timar J., Gyarmati Z., Tekes K., Harsing G.L., and Knoll J. Further proof that (-) deprenyl fails to facilitate mesolimbic dopaminergic activity. Pharmacol Biochem Behav 46 (1993) 709-714
65. Trozer T.N., Neff N.H., and Brodie B.B. Application of steady state kinetics to the synthesis rate and turnover time of serotonin in rat brain of normal and reserpine-treated rats. J Pharmacol Exp Ther 153 (1966) 177-182
66. Tsuda S., Murakami M., Matsusaka N., Kano K., Taniguchi K., and Sasaki Y.F. DNA damage induced by red food dyes orally administered to pregnant and male mice. Toxicol Sci 61 (2001) 92-99
67. Wade P.D., Marder E., and Siekevitz P. Characterization of transmitter release as a response of vertebrate neural tissue to erythrosin B. Brain Res 305 (1984) 259-270
68. Waterhouse B.D., Mihailoff G.A., Baack J.C., and Woodward D.J. Topographical distribution of dorsal and median raphe neurons projecting to motor, sensorimotor and visual cortical areas in the rat. J Comp Neurol 249 (1986) 460-476
69. 2+-ATPase rich sarcoplasmic reticulum vesicles photosensitized by erythrosin B. Chem Biol Interact 41 (1982) 313-325
70. Weiss B. Food additives as a source of behavioral disturbances in children. Neurotoxicology 7 (1986) 197-208
71. Yang H.Y., and Neff N.H. Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187 (1973) 365-371
72. Youdim M.B.H., and Finberg J.P.M. Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors. Clin Pharmacol Ther 56 (1994) 725-733